StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.76−0.02 (-2.11%)

Close on Nov 17, 2026Market cap $256.61MP/E –Yield –

Ocugen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ocugen's market cap was $325.62M on Nov 11, 2026, against $387.28M a year earlier. Over the last 5 years it ranged from $94.36M to $905.12M, with a median of $338.03M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$325.62M-22.8%
2025Dec 31, 2025$421.63M+80.4%
2024Dec 31, 2024$233.66M+58.4%
2023Dec 29, 2023$147.49M-47.6%
2022Dec 30, 2022$281.69M-68.9%
2021Dec 31, 2021$905.12M+205.3%
2020Dec 31, 2020$296.51M+5594.3%
2019Dec 31, 2019$5.21M-83.2%
2018Dec 31, 2018$30.94M-93.4%
2017Dec 29, 2017$467.12M+76.3%
2016Dec 30, 2016$265.01M-43.0%
2015Dec 31, 2015$464.57M–

More Ocugen figures

See a number that looks wrong?